"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." IF YOU COULD scale Everest and back in less than a week, would you do it? That's exactly what a British ...
How do you picture the peak of the world? Ice covering everything? No sign of life? Fluffy clouds floating around you? Yes… and no. Add tons of garbage and an endless line of people ascending to the ...
James is a published author with multiple pop-history and science books to his name. He specializes in history, space, strange science, and anything out of the ordinary.View full profile James is a ...
Xenon Pharmaceuticals (XENE) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...
Xenon ( ($XENE) ) has provided an announcement. Xenon Pharmaceuticals Inc. announced that President and CEO Ian Mortimer will present a company ...
Xenon Pharmaceuticals develops therapies for neurological disorders, with lead candidate drug XEN1101 aimed at treating epilepsy and major depressive disorder (MDD) by opening Kv7 potassium channels.
Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results